You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PLENVU Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Plenvu, and what generic alternatives are available?

Plenvu is a drug marketed by Salix and is included in one NDA. There are ten patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and fifty-eight patent family members in thirty-seven countries.

The generic ingredient in PLENVU is ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate profile page.

DrugPatentWatch® Generic Entry Outlook for Plenvu

There have been three patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

Indicators of Generic Entry

< Available with Subscription >

  Try a Trial

Drug patent expirations by year for PLENVU
Drug Prices for PLENVU

See drug prices for PLENVU

Paragraph IV (Patent) Challenges for PLENVU
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PLENVU For Oral Solution ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate 140 g, 5.2 g, 2.2.g, 48.11 g, 9 g and 7.54 g per pouch 209381 1 2018-12-06

US Patents and Regulatory Information for PLENVU

PLENVU is protected by ten US patents.

Patents protecting PLENVU

Compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Colonoscopy-preparation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Colonoscopy--preparation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS

Colon cleansing compositions and methods of use
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS

Compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS

Colonoscopy--preparation
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: FOR CLEANSING OF THE COLON IN PREPARATION FOR COLONOSCOPY IN ADULTS

Compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for PLENVU

When does loss-of-exclusivity occur for PLENVU?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 2500
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 13314442
Estimated Expiration: ⤷  Try a Trial

Patent: 15228962
Estimated Expiration: ⤷  Try a Trial

Patent: 18204694
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 2015005270
Estimated Expiration: ⤷  Try a Trial

Patent: 2016019914
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 84472
Estimated Expiration: ⤷  Try a Trial

Patent: 42089
Estimated Expiration: ⤷  Try a Trial

Patent: 16204
Estimated Expiration: ⤷  Try a Trial

China

Patent: 5007915
Estimated Expiration: ⤷  Try a Trial

Patent: 6102738
Estimated Expiration: ⤷  Try a Trial

Patent: 5154464
Estimated Expiration: ⤷  Try a Trial

Croatia

Patent: 0191007
Estimated Expiration: ⤷  Try a Trial

Denmark

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

Patent: 73248
Estimated Expiration: ⤷  Try a Trial

Patent: 77850
Estimated Expiration: ⤷  Try a Trial

Eurasian Patent Organization

Patent: 8866
Estimated Expiration: ⤷  Try a Trial

Patent: 7891
Estimated Expiration: ⤷  Try a Trial

Patent: 1500320
Estimated Expiration: ⤷  Try a Trial

Patent: 1600639
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

Patent: 16494
Estimated Expiration: ⤷  Try a Trial

Patent: 73248
Estimated Expiration: ⤷  Try a Trial

Patent: 77850
Estimated Expiration: ⤷  Try a Trial

Hong Kong

Patent: 06604
Estimated Expiration: ⤷  Try a Trial

Hungary

Patent: 43605
Estimated Expiration: ⤷  Try a Trial

India

Patent: 04DEN2015
Estimated Expiration: ⤷  Try a Trial

Ireland

Patent: 0130273
Estimated Expiration: ⤷  Try a Trial

Patent: 6410
Estimated Expiration: ⤷  Try a Trial

Israel

Patent: 7377
Estimated Expiration: ⤷  Try a Trial

Patent: 7170
Estimated Expiration: ⤷  Try a Trial

Patent: 9024
Estimated Expiration: ⤷  Try a Trial

Patent: 4374
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 57675
Estimated Expiration: ⤷  Try a Trial

Patent: 55391
Estimated Expiration: ⤷  Try a Trial

Patent: 77396
Estimated Expiration: ⤷  Try a Trial

Patent: 15527385
Estimated Expiration: ⤷  Try a Trial

Patent: 17507965
Estimated Expiration: ⤷  Try a Trial

Patent: 20073579
Estimated Expiration: ⤷  Try a Trial

Lithuania

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

Malaysia

Patent: 4758
Estimated Expiration: ⤷  Try a Trial

Patent: 8550
Estimated Expiration: ⤷  Try a Trial

Patent: 3378
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 9318
Estimated Expiration: ⤷  Try a Trial

Patent: 15003031
Estimated Expiration: ⤷  Try a Trial

Patent: 16011256
Estimated Expiration: ⤷  Try a Trial

Patent: 21005225
Estimated Expiration: ⤷  Try a Trial

Montenegro

Patent: 413
Estimated Expiration: ⤷  Try a Trial

Netherlands

Patent: 11424
Estimated Expiration: ⤷  Try a Trial

New Zealand

Patent: 5499
Estimated Expiration: ⤷  Try a Trial

Patent: 3017
Estimated Expiration: ⤷  Try a Trial

Patent: 3984
Estimated Expiration: ⤷  Try a Trial

Poland

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

Patent: 73248
Estimated Expiration: ⤷  Try a Trial

Patent: 77850
Estimated Expiration: ⤷  Try a Trial

Portugal

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

Patent: 73248
Estimated Expiration: ⤷  Try a Trial

Patent: 77850
Estimated Expiration: ⤷  Try a Trial

Serbia

Patent: 979
Estimated Expiration: ⤷  Try a Trial

Singapore

Patent: 201702005V
Estimated Expiration: ⤷  Try a Trial

Patent: 201807427R
Estimated Expiration: ⤷  Try a Trial

Patent: 202112138Q
Estimated Expiration: ⤷  Try a Trial

Patent: 201501713X
Estimated Expiration: ⤷  Try a Trial

Patent: 201606834Q
Estimated Expiration: ⤷  Try a Trial

Slovenia

Patent: 95163
Estimated Expiration: ⤷  Try a Trial

South Africa

Patent: 1501415
Estimated Expiration: ⤷  Try a Trial

Patent: 1603747
Estimated Expiration: ⤷  Try a Trial

Patent: 1605592
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 1771586
Estimated Expiration: ⤷  Try a Trial

Patent: 2234803
Estimated Expiration: ⤷  Try a Trial

Patent: 2257207
Estimated Expiration: ⤷  Try a Trial

Patent: 150054990
Estimated Expiration: ⤷  Try a Trial

Patent: 160130488
Estimated Expiration: ⤷  Try a Trial

Patent: 170098980
Estimated Expiration: ⤷  Try a Trial

Patent: 190137925
Estimated Expiration: ⤷  Try a Trial

Patent: 210063445
Estimated Expiration: ⤷  Try a Trial

Patent: 230010844
Estimated Expiration: ⤷  Try a Trial

Spain

Patent: 28459
Estimated Expiration: ⤷  Try a Trial

Patent: 31412
Estimated Expiration: ⤷  Try a Trial

Patent: 09386
Estimated Expiration: ⤷  Try a Trial

Patent: 28719
Estimated Expiration: ⤷  Try a Trial

Taiwan

Patent: 87238
Estimated Expiration: ⤷  Try a Trial

Patent: 56623
Estimated Expiration: ⤷  Try a Trial

Patent: 1416092
Estimated Expiration: ⤷  Try a Trial

Patent: 2017562
Estimated Expiration: ⤷  Try a Trial

Ukraine

Patent: 6546
Estimated Expiration: ⤷  Try a Trial

Patent: 3659
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering PLENVU around the world.

Country Patent Number Title Estimated Expiration
Portugal 3141251 ⤷  Try a Trial
Canada 3116204 COMPOSITION POUR NETTOYAGE DU COLON COMPRENANT DE L'ASCORBATE ET DU POLYETHYLENEGLYCOL (PEG) (COLON CLEANSING COMPOSITION COMPRISING ASCORBATE AND PEG) ⤷  Try a Trial
Hong Kong 1188115 結腸清洗組合物 (COLON CLEANSING COMPOSITIONS) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PLENVU

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3141251 122021000018 Germany ⤷  Try a Trial PRODUCT NAME: EIN ARZNEIMITTEL BESTEHEND AUS EINER KOMBINATION EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG FUER EINE ERSTE DOSIS UND EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG FUER EINE ZWEITE DOSIS, WOBEI DIE PHARMAZEUTISCHE ZUSAMMENSETZUNG FUER DIE ERSTE DOSIS AUS DEN WIRKSTOFFEN POLYETHYLENGLYCOL, NATRIUMSULFAT, NATRIUMCHLORID UND KALIUMCHLORID BESTEHT UND DIE PHARMAZEUTISCHE ZUSAMMENSETZUNG FUER DIE ZWEITE DOSIS AUS DEN; NAT. REGISTRATION NO/DATE: 98450.00.00 20180205; FIRST REGISTRATION: ISLAND IS/1/17/083/01 20171016
3141251 C202130017 Spain ⤷  Try a Trial PRODUCT NAME: COMBINACION DE PRINCIPIOS ACTIVOS EN DOS DOSIS, EN LA QUE LA PRIMERA DOSIS CONSISTE EN LOS PRINCIPIOS ACTIVOS POLIETILENGLICOL, SULFATO DE SODIO, CLORURO DE SODIO Y CLORURO DE POTASIO, Y LA SEGUNDA DOSIS CONSISTE EN LOS PRINCIPIOS ACTIVOS POLIETILENGLICOL, ACIDO ASCORBICO, ASCORBATO DE SODIO, CLORURO DE SODIO Y CLORURO DE POTASIO.; NATIONAL AUTHORISATION NUMBER: 82959-SE/H/1801/001/DC; DATE OF AUTHORISATION: 20180525; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): IS/1/17/083/01; DATE OF FIRST AUTHORISATION IN EEA: 20171016
3141251 132021000000044 Italy ⤷  Try a Trial PRODUCT NAME: UN PRODOTTO MEDICINALE COSTITUITO DA UNA COMBINAZIONE DI UNA PRIMA DOSE DI COMPOSIZIONE FARMACEUTICA E UNA SECONDA DOSE DI COMPOSIZIONE FARMACEUTICA, LA PRIMA DOSE DI COMPOSIZIONE FARMACEUTICA E COSTITUITA DAGLI INGREDIENTI ATTIVI POLIETILENGLICOLE, SOLFATO DI SODIO, CLORURO DI SODIO E CLORURO DI POTASSIO E LA SECONDA DOSE DI COMPOSIZIONE FARMACEUTICA E COSTITUITA DAGLI INGREDIENTI ATTIVI POLIETILENGLICOLE, ACIDO ASCORBICO, ASCORBATO DI SODIO, CLORURO DI SODIO E CLORURO DI POTASSIO.(PLENVU); AUTHORISATION NUMBER(S) AND DATE(S): IS/1/17/083/01, 20171016;045671017, 045671029, 045671031, 045671043, 045671056, 20171213
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.